FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1922019985> ?p ?o ?g. }

• W1922019985 endingPage "1022" @default.
• W1922019985 startingPage "1013" @default.
• W1922019985 abstract "The cannabinoid-1 receptor (CB1R) has been implicated in the control of energy balance. To explore the pharmacological utility of CB1R inhibition for the treatment of obesity, we evaluated the efficacy of <i>N</i>-[(1<i>S</i>,2<i>S</i>)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-{[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (MK-0364) and determined the relationship between efficacy and brain CB1R occupancy in rodents. MK-0364 was shown to be a highly potent CB1R inverse agonist that inhibited the binding and functional activity of various agonists with a binding <i>K</i>_i of 0.13 nM for the human CB1R in vitro. MK-0364 dose-dependently inhibited food intake and weight gain, with an acute minimum effective dose of 1 mg/kg in diet-induced obese (DIO) rats. CB1R mechanism-based effect was demonstrated for MK-0364 by its lack of efficacy in CB1R-deficient mice. Chronic treatment of DIO rats with MK-0364 dose-dependently led to significant weight loss with a minimum effective dose of 0.3 mg/kg (p.o.), or a plasma <i>C</i>_max of 87 nM. Weight loss was accompanied by the loss of fat mass. Partial occupancy (30–40%) of brain CB1R by MK-0364 was sufficient to reduce body weight. The magnitude of weight loss was correlated with brain CB1R occupancy. The partial receptor occupancy requirement for efficacy was also consistent with the reduced food intake of the heterozygous mice carrying one disrupted allele of CB1R gene compared with the wild-type mice. These studies demonstrated that MK-0364 is a highly potent and selective CB1R inverse agonist and that it is orally active in rodent models of obesity." @default.
• W1922019985 created "2016-06-24" @default.
• W1922019985 creator A5001772015 @default.
• W1922019985 creator A5011496113 @default.
• W1922019985 creator A5013452526 @default.
• W1922019985 creator A5017064292 @default.
• W1922019985 creator A5022587232 @default.
• W1922019985 creator A5024496957 @default.
• W1922019985 creator A5027973382 @default.
• W1922019985 creator A5029316647 @default.
• W1922019985 creator A5030570553 @default.
• W1922019985 creator A5033248703 @default.
• W1922019985 creator A5036570397 @default.
• W1922019985 creator A5036791099 @default.
• W1922019985 creator A5037639534 @default.
• W1922019985 creator A5041786534 @default.
• W1922019985 creator A5057685449 @default.
• W1922019985 creator A5059408264 @default.
• W1922019985 creator A5062103290 @default.
• W1922019985 creator A5063859878 @default.
• W1922019985 creator A5063946704 @default.
• W1922019985 creator A5065732763 @default.
• W1922019985 creator A5075465842 @default.
• W1922019985 creator A5075662890 @default.
• W1922019985 creator A5077153113 @default.
• W1922019985 creator A5079812405 @default.
• W1922019985 creator A5085609112 @default.
• W1922019985 creator A5090415864 @default.
• W1922019985 date "2007-02-27" @default.
• W1922019985 modified "2023-10-16" @default.
• W1922019985 title "Antiobesity Efficacy of a Novel Cannabinoid-1 Receptor Inverse Agonist, <i>N</i>-[(1<i>S</i>,2<i>S</i>)-3-(4-Chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-{[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (MK-0364), in Rodents" @default.
• W1922019985 cites W1491109154 @default.
• W1922019985 cites W1965019847 @default.
• W1922019985 cites W1970140633 @default.
• W1922019985 cites W1970418750 @default.
• W1922019985 cites W1970504819 @default.
• W1922019985 cites W1971698096 @default.
• W1922019985 cites W1975957035 @default.
• W1922019985 cites W1982928007 @default.
• W1922019985 cites W1985970204 @default.
• W1922019985 cites W1991132716 @default.
• W1922019985 cites W1999808927 @default.
• W1922019985 cites W2003396042 @default.
• W1922019985 cites W2006481049 @default.
• W1922019985 cites W2023354455 @default.
• W1922019985 cites W2029820981 @default.
• W1922019985 cites W2033818328 @default.
• W1922019985 cites W2036306731 @default.
• W1922019985 cites W2037412847 @default.
• W1922019985 cites W2047517646 @default.
• W1922019985 cites W2057103413 @default.
• W1922019985 cites W2058586676 @default.
• W1922019985 cites W2059977407 @default.
• W1922019985 cites W2075425261 @default.
• W1922019985 cites W2078765341 @default.
• W1922019985 cites W2091315563 @default.
• W1922019985 cites W2095758186 @default.
• W1922019985 cites W2112924959 @default.
• W1922019985 cites W2117311053 @default.
• W1922019985 cites W2127160263 @default.
• W1922019985 cites W2130587723 @default.
• W1922019985 cites W2150821313 @default.
• W1922019985 cites W2159395686 @default.
• W1922019985 cites W2165269657 @default.
• W1922019985 cites W2272316754 @default.
• W1922019985 cites W4229516859 @default.
• W1922019985 cites W4248980229 @default.
• W1922019985 doi "https://doi.org/10.1124/jpet.106.118737" @default.
• W1922019985 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17327489" @default.
• W1922019985 hasPublicationYear "2007" @default.
• W1922019985 type Work @default.
• W1922019985 sameAs 1922019985 @default.
• W1922019985 citedByCount "94" @default.
• W1922019985 countsByYear W19220199852012 @default.
• W1922019985 countsByYear W19220199852013 @default.
• W1922019985 countsByYear W19220199852014 @default.
• W1922019985 countsByYear W19220199852015 @default.
• W1922019985 countsByYear W19220199852016 @default.
• W1922019985 countsByYear W19220199852017 @default.
• W1922019985 countsByYear W19220199852018 @default.
• W1922019985 countsByYear W19220199852019 @default.
• W1922019985 countsByYear W19220199852020 @default.
• W1922019985 countsByYear W19220199852021 @default.
• W1922019985 countsByYear W19220199852022 @default.
• W1922019985 countsByYear W19220199852023 @default.
• W1922019985 crossrefType "journal-article" @default.
• W1922019985 hasAuthorship W1922019985A5001772015 @default.
• W1922019985 hasAuthorship W1922019985A5011496113 @default.
• W1922019985 hasAuthorship W1922019985A5013452526 @default.
• W1922019985 hasAuthorship W1922019985A5017064292 @default.
• W1922019985 hasAuthorship W1922019985A5022587232 @default.
• W1922019985 hasAuthorship W1922019985A5024496957 @default.
• W1922019985 hasAuthorship W1922019985A5027973382 @default.
• W1922019985 hasAuthorship W1922019985A5029316647 @default.
• W1922019985 hasAuthorship W1922019985A5030570553 @default.
• W1922019985 hasAuthorship W1922019985A5033248703 @default.
• W1922019985 hasAuthorship W1922019985A5036570397 @default.
• W1922019985 hasAuthorship W1922019985A5036791099 @default.

• next